Details
Product Name in the RMS: Rivastigmin Sandoz 9,5 mg/24 h - transdermales Pflaster
MR Number: AT/H/0483/002
Date of outcome: 18.11.2013
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
rivastigmine 9,5 mg/24 h |
Form | Transdermal patch |
MA Holder in the RMS |
Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Austria Austria |
RMS | Austria |
Date of last change | 10.02.2021 |
ATC-Code |
N06DA03 Rivastigmine |
CMS Country | Domestic Product Name |
---|---|
Belgium | Rivastigmin Sandoz 9.5 mg/24u Pleister voor transdermaal gebruik |
Denmark | |
France | |
Germany | Rivastigmin - Sandoz 9,5 mg / 24 h transdermales Pflaster |
Greece | |
Ireland | |
Italy | |
Netherlands | Rivastigmine Sandoz 9,5 mg/24 uur, pleisters voor transdermaal gebruik |
Norway | Rigmin |
Portugal | |
Romania | Rivastigmină Sandoz 9,5 mg/24 ore plasture transdermic |
Slovenia | |
Spain | |
Sweden | |
United Kingdom |
Documents | |
---|---|
PAR: | AT_H_0483_002_PAR.pdf (03.08.2015) |
FinalSPC: | AT_H_0483_002_FinalSPC.pdf (16.10.2020) |
FinalPL: | AT_H_0483_002_FinalPL.pdf (28.05.2019) |
FinalLabelling: | AT_H_0483_002_FinalLabelling.pdf (16.10.2020) |
Finalised Product Information: | AT_H_0483_002_FinalPI_1of3.pdf (18.11.2013) |
Finalised Product Information: | AT_H_0483_002_FinalPI_2of3.pdf (18.11.2013) |
Finalised Product Information: | AT_H_0483_002_FinalPI_3of3.pdf (18.11.2013) |